We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG Says Drugmakers Keep FDA’s Opioids Safety Program From Working Properly
OIG Says Drugmakers Keep FDA’s Opioids Safety Program From Working Properly
The FDA’s safety program designed to reduce opioid abuse and misuse is not well suited to tackling the continuing epidemic in the U.S., mainly due to a lack of cooperation from makers of opioids, the HHS Office of the Inspector General (OIG) says is a new report.